期刊文献+

Role of liver stem cells in hepatocarcinogenesis 被引量:7

Role of liver stem cells in hepatocarcinogenesis
下载PDF
导出
摘要 Liver cancer is an aggressive disease with a high mortality rate. Management of liver cancer is strongly dependent on the tumor stage and underlying liver disease. Unfortunately, most cases are discovered when the cancer is already advanced, missing the opportunity for surgical resection. Thus, an improved understanding of the mechanisms responsible for liver cancer initiation and progression will facilitate the detection of more reliable tumor markers and the development of new small molecules for targeted therapy of liver cancer. Recently, there is increasing evidence for the "cancer stem cell hypothesis", which postulates that liver cancer originates from the malignant transformation of liver stem/progenitor cells(liver cancer stem cells). This cancer stem cell model has important significance for understanding the basic biology of liver cancer and has profound importance for the development of new strategies for cancer prevention and treatment. In this review, we highlight recent advances in the role of liver stem cells in hepatocarcinogenesis. Our review of the literature shows that identification of the cellular origin and the signaling pathways involved is challenging issues in liver cancer with pivotal implications in therapeutic perspectives. Although the dedifferentiation of mature hepatocytes/cholangiocytes in hepatocarcinogenesis cannot be excluded, neoplastic transformation of a stem cell subpopulation more easily explains hepatocarcinogenesis. Elimination of liver cancer stem cells in liver cancer could result in the degeneration of downstream cells, which makes them potential targets for liver cancer therapies. Therefore, liver stem cells could represent a new target for therapeutic approaches to liver cancer in the near future. Liver cancer is an aggressive disease with a high mortality rate. Management of liver cancer is strongly dependent on the tumor stage and underlying liver disease. Unfortunately, most cases are discovered when the cancer is already advanced, missing the opportunity for surgical resection. Thus, an improved understanding of the mechanisms responsible for liver cancer initiation and progression will facilitate the detection of more reliable tumor markers and the development of new small molecules for targeted therapy of liver cancer. Recently, there is increasing evidence for the "cancer stem cell hypothesis", which postulates that liver cancer originates from the malignant transformation of liver stem/progenitor cells(liver cancer stem cells). This cancer stem cell model has important significance for understanding the basic biology of liver cancer and has profound importance for the development of new strategies for cancer prevention and treatment. In this review, we highlight recent advances in the role of liver stem cells in hepatocarcinogenesis. Our review of the literature shows that identification of the cellular origin and the signaling pathways involved is challenging issues in liver cancer with pivotal implications in therapeutic perspectives. Although the dedifferentiation of mature hepatocytes/cholangiocytes in hepatocarcinogenesis cannot be excluded, neoplastic transformation of a stem cell subpopulation more easily explains hepatocarcinogenesis. Elimination of liver cancer stem cells in liver cancer could result in the degeneration of downstream cells, which makes them potential targets for liver cancer therapies. Therefore, liver stem cells could represent a new target for therapeutic approaches to liver cancer in the near future.
出处 《World Journal of Stem Cells》 SCIE CAS 2014年第5期579-590,共12页 世界干细胞杂志(英文版)(电子版)
基金 Supported by The Special Research Foundation of the National Natural Science Foundation of China,No.81172068
  • 相关文献

参考文献12

  • 1Xu-Bo Wu Department of General Surgery,Central Hospital of Minhang District,Ruijin Medical Group,Shanghai 201199,China,Ran Tao Center for Organ Transplantation,Department of General Surgery,Ruijin Hospital,Shanghai Jiaotong University School of Medicine,Shanghai 200025,China.Hepatocyte differentiation of mesenchymal stem cells[J].Hepatobiliary & Pancreatic Diseases International,2012,11(4):360-371. 被引量:5
  • 2Inneke Willekens,Anne Hoorens,Caroline Geers,Bart Op de Beeck,Frederik Vandenbroucke,Johan de Mey.Combined hepatocellular and cholangiocellular carcinoma presenting with radiological characteristics of focal nodular hyperplasia[J].World Journal of Gastroenterology,2009,15(31):3940-3943. 被引量:4
  • 3Kanwal Rehman,Muhammad Javed Iqbal,Nureen Zahra,Muhammad Sajid Hamid Akash.Liver Stem Cells: From Preface to Advancements[J].Current Stem Cell Research & Therapy.2014(1) 被引量:1
  • 4Su Yeon An,Jiyou Han,Hee-Joung Lim,Seo-Young Park,Ji Hyang Kim,Byung-Rok Do,Jong-Hoon Kim.Valproic acid promotes differentiation of hepatocyte-like cells from whole human umbilical cord-derived mesenchymal stem cells[J].Tissue and Cell.2013 被引量:1
  • 5Wen-Juei Jeng,Hsin-Hua Tsai,Fang-Yu Chang,Hsin-I Hsiau,Ming-Che Yu,I-Shyan Sheen,Wen-Juei Jeng.Activation of the sonic hedgehog signaling pathway occurs in the CD133 positive cells of mouse liver cancer Hepa 1–6 cells[J].OncoTargets and Therapy (default).2013(default) 被引量:1
  • 6FangJun Yuan,Wenbo Zhou,Can Zou,Zhiyun Zhang,Hongsheng Hu,Zongqing Dai,YouShun Zhang.Expression of Oct4 in HCC and modulation to wnt/β-catenin and TGF-β signal pathways[J].Molecular and Cellular Biochemistry (-).2010(1-2) 被引量:2
  • 7Haraguchi, Naotsugu,Ishii, Hideshi,Mimori, Koshi,Tanaka, Fumiaki,Ohkuma, Masahisa,Kim, Ho Min,Akita, Hirofumi,Takiuchi, Daisuke,Hatano, Hisanori,Nagano, Hiroaki,Barnard, Graham F,Doki, Yuichiro,Mori, Masaki.CD13 is a therapeutic target in human liver cancer stem cells[J]. Journal of Clinical Investigation . 2010 (9) 被引量:7
  • 8Ling Yin,Omaida C. Velazquez,Zhao-Jun Liu.Notch signaling: Emerging molecular targets for cancer therapy[J]. Biochemical Pharmacology . 2010 (5) 被引量:3
  • 9ZhengZhu,XiangfangHao,MingxiaYan,MingYao,ChaoGe,JianrenGu,JinjunLi.Cancer stem/progenitor cells are highly enriched in CD133<sup>+</sup>CD44<sup>+</sup> population in hepatocellular carcinoma[J].Int J Cancer.2010(9) 被引量:3
  • 10Raphael Kopan,Ma. Xenia G. Ilagan.The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism[J].Cell.2009(2) 被引量:4

二级参考文献104

  • 1Xiao-Feng Yang.Immunology of Stem Cells and Cancer Stem Cells[J].Cellular & Molecular Immunology,2007,4(3):161-171. 被引量:7
  • 2Fukukura Y, Taguchi J, Nakashima O, Wada Y, Kojiro M. Combined hepatocellular and cholangiocarcinoma: correlation between CT findings and clinicopathological features. J Comput Assist Tomogr 1997; 21: 52-58. 被引量:1
  • 3Ebied O, Federle MP, Blachar A, Brancatelli G, Grazioli L, Cazals-Hatem D, Dondero F, Vilgrain V. Hepatocellular-cholangiocarcinoma: helical computed tomography findings in 30 patients. J Comput Assist Tomogr 2003; 27: 117-124. 被引量:1
  • 4Toh CH, Cheung YC, Ng SH, Lin CY, Chan SC, Ng KK. Combined hepatocellular-cholangiocarcinoma: a case report. Int J Clin Pract 2004; 58: 1170-1173. 被引量:1
  • 5Uenishi T, Hirohashi K, Shuto T, Yamamoto T, Kubo S, Tanaka H, Ikebe T, Kinoshita H. Surgery for mixed hepatocellular and cholangiocellular carcinoma. Hepatogastroenterology 2000; 47: 832-834. 被引量:1
  • 6Hashimoto T, Nakamura H, Hori S, Tomoda K, Mitani T, Murakami T, Kozuka T, Monden M, Wakasa K, Sakurai M. MR imaging of mixed hepatocellular and cholangiocellular carcinoma. Abdom Imaging 1994; 19: 430-432. 被引量:1
  • 7Huppertz A, Haraida S, Kraus A, Zech CJ, Scheidler J, Breuer J, Helmberger TK, Reiser MF. Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT--initial observations. Radiology 2005; 234: 468-478. 被引量:1
  • 8Lee WS, Lee KW, Heo JS, Kim SJ, Choi SH, Kim YI, Joh JW. Comparison of combined hepatocellular and cholangiocarcinoma with hepatocellular carcinoma and intrahepatic cholangiocarcinoma. Surg Today 2006; 36: 892-897. 被引量:1
  • 9Sasaki A, Kawano K, Aramaki M, Ohno T, Tahara K, Takeuchi Y, Yoshida T, Kitano S. Clinicopathologic study of mixed hepatocellular and cholangiocellular carcinoma: modes of spreading and choice of surgical treatment by reference to macroscopic type. J Surg Oncol 2001; 76: 37-46. 被引量:1
  • 10Lin G, Toh CH, Wu RC, Ko SF, Ng SH, Chou WC, Tseng JH. Combined hepatocellular cholangiocarcinoma: prognostic factors investigated by computed tomography/magnetic resonance imaging. Int J Clin Pract 2008; 62: 1199-1205. 被引量:1

共引文献63

同被引文献44

引证文献7

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部